strips placed below. The membrane had 0.4 mm pores that allowed the cytokines released from the CD4þT cells to reach the SM but prevented direct contact between cells. We found a significant increase in Vmax when the SM were in contact with the T cells (0.3250.02 l/s) compared to the co-culture without contact (0.2550.01 l/s) or compared to the SM alone (0.2450.01 l/s; p=0.01). Thus, contact between SM and CD4þT cells is necessary for modulation of SM contractile properties and this may be mediated, at least in part, by increases in (þ)insert myosin heavy chain and MLCK expression. Supported by: CIHR, NIH-RO1HL103405. St. Olaf College, Northfield, MN, USA. We have examined the structural consequences of methionine (Met) oxidation in the calcium-sensing muscle regulatory protein calmodulin (CaM) using molecular dynamics simulations. Protein oxidation by reactive oxygen species (ROS), and subsequent reduction by the antioxidant enzyme methionine sulfoxide reductase, has emerged as a crucial cell regulatory mechanism. In the context of oxidative stress, protein oxidation is implicated in disease progression and biological aging. Our goal is to bridge our understanding of muscle dysfunction and protein oxidation with atomic-level insights into site-specific methionine oxidation and calmodulin structural dynamics. We have carried out multiple 500 ns molecular dynamics simulations of explicitly solvated calmodulin, both the calcium-bound (1cll) and apo (1cfc) crystal structures. Results from preliminary simulations suggest that the structure of calcium bound CaM is structurally insensitive to methionine oxidation, while methionine oxidation in apo CaM causes considerable changes the relative orientation of the N-ter and C-ter lobes. Our work is a component of a larger study in which spectroscopic distance measurements and nuclear magnetic resonance experiments are being carried out for site-specifically oxidized CaM in both the calcium bound and apo biochemical states. We expect that our in silico results will bring atomic-level insight to spectroscopic measurements, and will be integral to creating a more complete model for oxidation-induced changes in calmodulin structural dynamics. Further, we anticipate that our results will be applicable to the many biological and pharmaceutical contexts in which a detailed understanding of protein oxidation, function and structure relationships is sought. This work is supported by an NIH grant to Dave Thomas (2R37AG026160-06) and the Minnesota Supercomputing Institute.
St. Olaf College, Northfield, MN, USA. We have examined the structural consequences of methionine (Met) oxidation in the calcium-sensing muscle regulatory protein calmodulin (CaM) using molecular dynamics simulations. Protein oxidation by reactive oxygen species (ROS), and subsequent reduction by the antioxidant enzyme methionine sulfoxide reductase, has emerged as a crucial cell regulatory mechanism. In the context of oxidative stress, protein oxidation is implicated in disease progression and biological aging. Our goal is to bridge our understanding of muscle dysfunction and protein oxidation with atomic-level insights into site-specific methionine oxidation and calmodulin structural dynamics. We have carried out multiple 500 ns molecular dynamics simulations of explicitly solvated calmodulin, both the calcium-bound (1cll) and apo (1cfc) crystal structures. Results from preliminary simulations suggest that the structure of calcium bound CaM is structurally insensitive to methionine oxidation, while methionine oxidation in apo CaM causes considerable changes the relative orientation of the N-ter and C-ter lobes. Our work is a component of a larger study in which spectroscopic distance measurements and nuclear magnetic resonance experiments are being carried out for site-specifically oxidized CaM in both the calcium bound and apo biochemical states. We expect that our in silico results will bring atomic-level insight to spectroscopic measurements, and will be integral to creating a more complete model for oxidation-induced changes in calmodulin structural dynamics. Further, we anticipate that our results will be applicable to the many biological and pharmaceutical contexts in which a detailed understanding of protein oxidation, function and structure relationships is sought. This work is supported by an NIH grant to Dave Thomas (2R37AG026160-06) and the Minnesota Supercomputing Institute.
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Cardiac Thin Filament Activation Modulation by Stretch Younss Ait Mou, Pieter P. de Tombe. Loyola University Chicago, Maywood, IL, USA. Myofilament Length Dependent Activation (LDA) forms the cellular basis of the Frank-Starling law observed on the heart. LDA has been studied intensively and appears to be modulated through various mechanisms, such as the composition of the contractile proteins and their phosphorylation status. However, the cellular molecular mechanisms that underlie this phenomenon are still not well characterized. The aim of our study is to determine whether LDA is regulated through cTnC structural changes upon stretch. Accordingly, we used a single attached skinned cardiac myocyte in combination with confocal fluorescent measurement. using this technique, we found that stretch of a relaxed cell, in the absence of Ca 2þ , resulted in marked alterations of cTnC structure as reported by cTnC-T53C-IAF confocal fluorescence. Moreover, titin mutant cells show a drastic alteration of both passive tension and myofilament sensitivity to calcium (pCa50) upon stretch. Consistent with this finding, by employing time-resolved x-ray diffraction of intact, electrically stimulated rat myocardium, we found marked changes in troponin and myosin structure upon stretch in the diastolic phase (i.e. when cross-bridges are not active). Moreover, we repeated these x-ray experiments using rat myocardium that expresses an unusually long titin molecule and found that, when compared to WT, diastolic stretch in these muscles did not cause structural changes in troponin and myosin structures. These results strongly implicate titin to be the molecule that transmits the length signal for LDA.
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Effects of TNI Inhibitory Peptide Mutation on Troponin Dynamics Julie J. Mouannes Kozaili, Devanand Kowlessur, Larry S. Tobacman. University of Illinois at Chicago, Chicago, IL, USA. Striated muscles are relaxed under low calcium concentration conditions due to actions of the thin filament protein troponin. To investigate this regulatory mechanism, this project studies the dynamic behavior of a mutant troponin in which an 11-residue segment of cardiac troponin I, known as the inhibitory region, has been converted to a Gly-Ala flexible linker. The functional effects of this mutation were previously characterized. (Mouannes Kozaili, et al, JBC 2010) . The mutation impairs rather than abolishes troponin's inhibitory function, and thin filaments retain cooperative Ca 2þ -sensitive properties. Previous work from our lab has mapped the dynamic behavior of the Ca 2þ -saturated cardiac troponin core domain at 10 C and 25 C using hydrogen/deuterium exchange (HDX)-mass spectrometry. (Kowlessur D, et al, JBC 2010 , JBC 2010a . Also, another previous study established the effects of Ca 2þ binding to site II of TnC in the NH 2 domain on troponin dynamics, using the TnC mutant D65A/E66A (CBMII-TnC) (Manuscript Submitted). To better understand troponin function, the dynamic behavior of site II Ca 2þ -free troponin (i.e. troponin with CBMII-TnC) containing the TnI inhibitory peptide mutation is investigated in this work. HDX can determine the effect of a specific alteration in a protein on the dynamics of all parts of that protein.
The results show that mutation of the inhibitory region alters troponin dynamics both locally and at distance. The inhibitory region replacement slowed the dynamics of some regions, had no effect on others, and increased the dynamic properties of much of the troponin coiled-coil. Some of the effects of Ca 2þ removal on troponin dynamics were dependent upon presence of the intact inhibitory region. The current work indicates a clear and complex effect of the inhibitory peptide region on many portions of troponin. -binding to TnC, leading to tropomyosin movement and unblocking of myosin binding sites on actin. To elucidate this regulatory mechanism, the 3D organization of the regulatory proteins on the thin filament must be determined. While tropomyosin arrangement has been determined by 3DEM using helical reconstruction and IHRSR analysis, troponin was not visualized due to helical averaging. To solve the structure of native cardiac thin filaments in low-Ca 2þ , we have used single particle reconstruction of negatively stained specimens, without imposing actin helical symmetry. To acquire identical particles for reconstruction, a crosscorrelation approach was applied to determine the axial position of troponin. The reconstruction had a resolution of 2.5 nm. Nine different reference models were used to test for any model bias in the reconstruction. Eight were variations of an earlier model (Pirani et al., JMB, 2006) , with troponin translated 52 nm along or 520 o azimuthally around the filament, or tilted 515 o radially or azimuthally; one model used a sphere to represent troponin. With eight of the models, the reconstruction converged to the same final structure, which clearly showed F-actin, tropomyosin and troponin densities. Consistency between reconstructions from multiple different models indicates that the troponin densities are reliable. Atomic models of tropomyosin and actin fitted well into the reconstruction. The densities attributable to troponin were also well fitted by the cardiac troponin core domain (Takeda et al., Nature 2003) , with the Tn ''IT'' arm projecting at~50 o to the filament axis (cf. Knowles et al., JMB 2012). The core domain orientation and the TnT tail, observed as a widening of tropomyosin toward the barbed end of filaments, established the polarity of troponin on the thin filament. Our 3DEM also is consistent with crosslinking data localizing troponin on actin-tropomyosin. Institute of Physics, Faculty of Mathematics and Physics, Charles University, Prague, Czech Republic. The transient receptor potential ankyrin 1 channel (TRPA1) is a versatile sensory channel that is gated by depolarizing voltages, deep cooling, membrane deformation, and structurally diverse compounds which include proalgesic agents such as allyl isothiocyanate. How these disparate stimuli converge on the channel protein to open the ion-conducting pore has not yet been fully resolved. The overall architecture of TRP channels shows clear similarities to that seen in the well characterized voltage-gated potassium channels. Here, activation of the voltage sensors in the fourth transmembrane segment (S4) is transduced into pore opening via coupling of the S4-S5 linker to the C-terminal S6 segment. In TRPA1, the gain-of-function mutation N855S located in the S4-S5 region has been associated with familial episodic pain syndrome. In an attempt to elucidate the role of the S4-S5 linker and its putative interaction(s) with S6 or the first C-terminal helix in the voltage-dependent gating of TRPA1, we used site-directed mutagenesis, whole-cell electrophysiology, single-channel recording, and molecular dynamics simulations. The chargereversal mutations K868E and K969E resulted in a decrease in the rectification index compared to wild-type TRPA1 channels, and a virtually voltageindependent conductance-voltage (G-V) relationship. This effect was also observed in the adjacent charge-neutralizing mutant H970A, but was less pronounced in charge-reversal H970D. These results indicate that positively charged residues in the S4-S5 linker and the helix adjacent to the C-terminal S6 segment play a vital role in the voltage-dependent gating of TRPA1. Human skin is constantly exposed to solar ultraviolet radiation (UVR), the most prevalent environmental carcinogen. Humans have the unique ability among mammals to respond to UVR by increasing their skin pigmentation, a protective process driven by melanin synthesis in epidermal melanocytes. However, the mechanism used by melanocytes to detect and respond to UVR is not well understood. Here we report that transient receptor potential A1 (TRPA1) ion channels expressed in human melanocytes are activated by UVR and mediate early melanin synthesis. We show that in human epidermal melanocytes (HEMs) physiological doses of UVR activate a retinal-dependent current mediated by TRPA1. The UVR photocurrent density was reduced by TRPA1 antagonists and abolished in HEMs expressing TRPA1-targeted miRNA. The TRPA1 photocurrent is UVA specific and requires G protein signaling, providing the first evidence for TRPA1 function in mammalian phototransduction. In HEMs, TRPA1 activation contributes to UVR-induced calcium responses to mediate downstream cellular effects. Remarkably, the UVR-induced and retinal-dependent early increase in cellular melanin content was significantly reduced in HEMs treated with TRPA1 antagonists and abolished in HEMs expressing TRPA1-targeted miRNA, suggesting that TRPA1 is required for early melanin synthesis. Our results show that TRPA1 is essential for a novel extraocular phototransduction pathway in human melanocytes that is activated by physiological doses of UVR and results in early melanin synthesis. Bristol University, Bristol, United Kingdom. Canonical transient receptor potential channels (TRPC3/6) are mechanosensitive, receptor-and store-operated channels that mediate Ca 2þ /Na þ influx into cells. TRPC3/6 are implicated in the regulation of vascular tone, cell growth, proliferation and pathological hypertrophy. Potent and selective small molecule TRPC3/6 agonist and antagonist tools had been lacking to study the functions of TRPC3/6. We report here potent, small molecule agonist (GSK1702934A) and antagonists (GSK417651A and GSK2293017A) of TRPC3/6. Whole-cell patch-clamp experiments demonstrated that GSK1702934A activated TRPC3 and TRPC6 current in HEK293 cells transduced with recombinant human TRPC3 or TRPC6 with an EC 50 of0
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.08 mM and 0.44 mM, respectively. GSK417651A inhibited both TRPC3 and TRPC6 current with IC 50 s of~0.04 mM. A more potent TRPC3/6 antagonist GSK2293017A exhibited an IC 50 of~0.01 mM. GSK417651A was likely acting on TRPC3/6 from the extracellular side, because dialyzing the cells with 10 mM GSK417651A in the pipette solution did not prevent the activation of TRPC6. In the rat cardiomyocyte like cell line H9C2, GSK1702934A (1 mM) activated TRPC6-like current which was completely blocked by GSK417651A (1 mM). TRPC3/6 activator GSK1702934A (1 mM) transiently increased the perfusion pressure of isolated rat heart retrogradely perfused via aortic cannulation. This effect was completely eliminated by pretreatment with the TRPC3/6 blocker GSK2293017A (1 mM). IV bolus of GSK1702934A (0.3~3 mg/kg) transiently increased blood pressure by 15~35 mmHg in conscious Sprague Dawley rats. This blood pressure effect was dose-dependently inhibited by pretreatment of GSK2293017A (2.5~250 mg/kg/min infusion for 30 min) with complete inhibition occurring at a free plasma concentration of 0.81 mM. Therefore, these small molecule agonist and antagonists could be useful tools to help understand the characteristics and functions of TRPC3/6 in tissues and animals. et al., 1999, Nature) . In contrary, we have recently reported that the depletion of PI(4,5)P 2 byitself act as a potent negative regulator to all these channels even in the presence of DAG (Imai et al., 2012, J. of Physiol.) . Stimulation upon the vasoconstrictile receptors coupled with PLC theoretically causes inseparable bimodal effect to these TRPC channels, i.e. activation and inhibition by DAG production and coincident PI(4,5)P 2 reduction or depletion which is corresponding to the strength of PLC activities. Here, to elucidate such self-limiting regulatory function coupled to PI(4,5)P 2 -DAG signal, we simultaneously measure TRPC6/7 currents in the whole-cell configuration and PI(4,5)P 2 dynamics by FRET using PI(4,5)P 2 binding PH-domain sensor proteins in the various strength of muscarinic-or vasopressin-receptor stimulation. Our simultaneous detection approach reveals good kinetics correlation between TRPC activation/ fast-inactivation and PI(4,5)P 2 depletion. Furthermore, a simple self-limiting regulation model wherein experimentally determined PI(4,5)P 2 binding constants incorporated aware an emergence of fast recovery of PI(4,5)P 2 to produce slow inactivation (plateau phase) of TRPC currents. We find that such model implicated PI(4,5)P 2 enhancement can be reproduced after the fast PI(4,5)P 2 depletion under the robust agonist stimulation by the local FRET measurement near the channels. Hence, these data indicates that self-limiting regulation coupled to PI(4,5)P 2 -DAG signal is the pivotal mechanism to understand the receptor-PLC mediated TRPC3/6/7 channels activity.
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2325-Pos Board B344 RASD1 Independently Activates TRPC4 through Gai of GPCR Jinhong Wie, Insuk So. School of medicine Seoul National University, Seoul, Korea, Republic of. Canonical transient receptor potential (TRPC) channels have six transmembrane (6-TM) domains and are Ca 2þ -permeable and non-selective cation channels. It is generally speculated that TRPC channels are activated by stimulation of Gq-PLC-coupled receptors and oxidation. Activator of G-protein signaling1 (AGS1 or RASD1), the ras-related protein, interacts with Gi/Go and activates heterotrimeric G-protein signaling systems independent of G-protein-coupled receptor (GPCR). It is previously reported that AGS1 is related to GIRK channel and Ca 2þ channel. However it is unknown whether AGS1 is associated with TRPC channels. We assumed that AGS1 might regulate TRPC4 channel, since AGS1 interacts with Gi/Go and TRPC4 is activated by Gi/o subunits. Here, we measured whole cell current of TRPC4/5 after the co-expression of TRPC4 or TRPC5 with constitutively active form of small GTPases in HEK293 cells. AGS1 (CA) mutant (Q to L) activated TRPC4 (38.8 5 7.2 pA/pF) without GTPgS and independently of GPCR. Pertussis toxin (PTX), Ga i specific inhibitor, blocked RASD1-activated TRPC4 current (3.451.6 pA/pF). When coexpressed with dominant negative Ga i protein subtype, TRPC4 activation by RASD1 was completely inhibited. With previous report that TRPC4 are activated primarily by selective Gai subunits rather than Ga q , these results suggest that AGS1 activates TRPC4 channel through modulating Gai subunits and AGS1 is a new activator for TRPC4 channel. 
